Capstone Therapeutics Announces That Its Joint Venture, LipimetiX Development, Inc., Has Closed a Series B-1 Preferred Stock Offering
Author Archive: AZBio
New Medical Device User Fee Agreement Sets the Stage For Continued Progress in FDA Performance
Latest Deal Builds on Success of MDUFA IIIContinue reading
Avery Therapeutics Awarded NIH SBIR
Avery Therapeutics, Inc., a pre-clinical stage company dedicated to advancing tissue-engineered therapeutics to treat diseases and injuries to human muscle, has been awarded a $483k SBIR grant from the National Institutes of Health to develop manufacturing, cryopreservation, storage and reconstitution methods for Avery’s first product MyCardia™. Continue reading
Marni Landry of the Paradise Valley High School CREST Program Named Arizona Bioscience Educator of the Year
The Arizona Bioindustry Association has named Marni Landry, BS, M.Ed of Paradise Valley High School as the 2016 Michael A. Cusanovich Bioscience Educator of the Year in recognition of her dedication in the classroom and her commitment to designing bioscience education programs and curriculum to help inspire and create tomorrow’s bioscience leaders.Continue reading
Insys Therapeutics Announces First Patient Enrolled in Phase II Trial for the Treatment of Cocaine Dependence Using Pharmaceutical Cannabidiol
Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced enrollment of the first patient in a Phase II clinical trial for the treatment of cocaine dependence using its pharmaceutical cannabidiol (CBD) product candidate. The study is being conducted by Dr. Didier Jutras-Aswad, MD, at the University of Montreal Hospital Research Center (CRCHUM) and is supported by the Canadian Institutes of Health Research (CIHR) and the Company.Continue reading
FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke.
Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients.
$7M NIH Asthma Grant to UA College of Medicine – Tucso
Led by Dr. Monica Kraft, researchers will use the National Institutes of Health grant to conduct a five-year study to investigate the interrelationship of genetic mediators to reduce lung inflammation and attacks in asthma patients.Continue reading
Green named Health Care Hero finalist for Zika virus detection device
Green is a synthetic biologist and an assistant professor in the Biodesign Center for Molecular Design and Biomimetics at Arizona State University. In this field, he looks for ways to repurpose and engineer biological components for practical applications. These types of discoveries are increasingly moving from laboratories to patient care….Continue reading
Tech Launch Arizona Sets Performance Records in 3rd Full Year
The technology commercialization office of the University of Arizona, Tech Launch Arizona, reports that it had an outstanding year during FY 2016 (July 1, 2015 to June 30, 2016) and that UA inventor engagement in technology commercialization activities has attained all-time highs as evidenced by key performance indicators. In addition to technology commercialization, the Tech Parks Arizona component of TLA finished FY 2016 with record accomplishments, as well.Continue reading
Study Results with Castle Biosciences’ Uveal Melanoma Gene Expression Test Published in Journal of Oncology
Data confirm accuracy of DecisionDx-UM and demonstrate impact of test results on patient care and follow-upContinue reading